EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials

PURPOSE: To assess the treatment effect of intravitreal aflibercept and ranibizumab in Asian patients with neovascular age-related macular degeneration. METHODS: We evaluated data from VIEW 1 and VIEW 2, comparing functional and morphologic outcomes at Week 96 between intravitreal aflibercept 2 mg m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Tien Yin, Cheung, Chui Ming Gemmy, Lai, Timothy Y. Y., Chen, Shih-Jen, Lee, Won Ki, Yoon, Young Hee, Iida, Tomohiro, Tueckmantel, Claudia, Sowade, Olaf, Ogura, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2019
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410967/
https://www.ncbi.nlm.nih.gov/pubmed/29280937
http://dx.doi.org/10.1097/IAE.0000000000001986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410967/
https://www.ncbi.nlm.nih.gov/pubmed/29280937
http://dx.doi.org/10.1097/IAE.0000000000001986

Ejemplares similares